Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 544

1.

Anemia and chronic heart failure implications and treatment options.

Anand IS.

J Am Coll Cardiol. 2008 Aug 12;52(7):501-11. doi: 10.1016/j.jacc.2008.04.044. Review.

2.

The interaction between heart failure and other heart diseases, renal failure, and anemia.

Silverberg DS, Wexler D, Iaina A, Schwartz D.

Semin Nephrol. 2006 Jul;26(4):296-306. Review.

PMID:
16949468
3.

Mechanisms and treatment of anemia in chronic heart failure.

Katz SD.

Congest Heart Fail. 2004 Sep-Oct;10(5):243-7. Review.

4.

Anemia in heart failure: implications, management, and outcomes.

Paul S, Paul RV.

J Cardiovasc Nurs. 2004 Nov-Dec;19(6 Suppl):S57-66. Review. Erratum in: J Cardiovasc Nurs. 2005 Jan-Feb;20(1):17.

PMID:
15529075
5.

Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure.

van der Putten K, Braam B, Jie KE, Gaillard CA.

Nat Clin Pract Nephrol. 2008 Jan;4(1):47-57. Review.

PMID:
18094727
6.

Etiology and management of anemia in patients with heart failure: how much iron is missing?

Beck da Silva L, Rohde LE, Clausell N.

Congest Heart Fail. 2008 Jan-Feb;14(1):25-30. Review.

PMID:
18256566
7.

Erythropoietin in heart failure and other cardiovascular diseases: hematopoietic and pleiotropic effects.

Manolis AS, Tzeis S, Triantafyllou K, Michaelidis J, Pyrros I, Sakellaris N, Kranidis A, Melita H.

Curr Drug Targets Cardiovasc Haematol Disord. 2005 Oct;5(5):355-75. Review.

PMID:
16248829
8.

The role of anemia in the progression of congestive heart failure. Is there a place for erythropoietin and intravenous iron?

Silverberg DS, Wexler D, Iaina A.

J Nephrol. 2004 Nov-Dec;17(6):749-61. Review.

PMID:
15593047
9.

Aggressive therapy of congestive heart failure and associated chronic renal failure with medications and correction of anemia stops or slows the progression of both diseases.

Silverberg DS, Wexler D, Blum M, Sheps D, Schwartz D, Yachnin T, Baruch R, Tchebiner J, Zubkov A, Shaked M, Steinbruch S, Keren G, Iaina A.

Perit Dial Int. 2001;21 Suppl 3:S236-40.

PMID:
11887828
10.

Pathogenesis of anemia in cardiorenal disease.

Anand IS.

Rev Cardiovasc Med. 2005;6 Suppl 3:S13-21. Review.

PMID:
16340934
11.

Therapy insight: congestive heart failure, chronic kidney disease and anemia, the cardio-renal-anemia syndrome.

Iaina A, Silverberg DS, Wexler D.

Nat Clin Pract Cardiovasc Med. 2005 Feb;2(2):95-100. Review.

PMID:
16265380
12.

Anemia in chronic heart failure: etiology and treatment options.

Westenbrink BD, de Boer RA, Voors AA, van Gilst WH, van Veldhuisen DJ.

Curr Opin Cardiol. 2008 Mar;23(2):141-7. doi: 10.1097/HCO.0b013e3282f43025. Review.

PMID:
18303527
13.

Anemia as a risk factor and therapeutic target in heart failure.

Felker GM, Adams KF Jr, Gattis WA, O'Connor CM.

J Am Coll Cardiol. 2004 Sep 1;44(5):959-66. Review.

14.
15.

The benefits of IV iron therapy in treating anemia in patients with renal disease and comorbid cardiovascular disease.

Singh AK, Hertello P.

Nephrol Nurs J. 2005 Mar-Apr;32(2):199-206; quiz 207-8. Review.

PMID:
15889804
16.

Erythropoietin in heart failure.

Silverberg DS, Wexler D, Blum M, Iaina A, Sheps D, Keren G, Schwartz D.

Semin Nephrol. 2005 Nov;25(6):397-403. Review.

PMID:
16298262
17.

Anemia in the critically ill.

Shander A.

Crit Care Clin. 2004 Apr;20(2):159-78. Review.

PMID:
15135458
18.

Congestive heart failure-related anemia and a role for erythropoietin.

Akram K, Pearlman BL.

Int J Cardiol. 2007 May 2;117(3):296-305. Epub 2006 Aug 9. Review.

PMID:
16901559
19.

Anemia in chronic heart failure: pathogenetic mechanisms.

Okonko DO, Anker SD.

J Card Fail. 2004 Feb;10(1 Suppl):S5-9. Review.

PMID:
15007793
20.

Recognition and treatment of anemia in the setting of heart failure due to systolic left ventricular dysfunction.

Howlett JG.

Expert Rev Cardiovasc Ther. 2008 Feb;6(2):199-208. doi: 10.1586/14779072.6.2.199. Review.

PMID:
18248274

Supplemental Content

Support Center